<DOC>
	<DOCNO>NCT00902369</DOCNO>
	<brief_summary>This Phase II , multi-centre study consist 2 part . Part 1 : Clinical Pharmacology Study ( drug-drug interaction AK106-001616 methotrexate ) Part 2 : Proof Concept Study</brief_summary>
	<brief_title>A Study AK106-001616 Patients With Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Diagnosis RA ( class I III ) Stable dose methotrexate ( least 12 week ) Pregnant breastfeed Abnormal screen laboratory test value consider clinically significant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>AK106-001616</keyword>
</DOC>